Casticin suppresses the carcinogenesis of small cell lung cancer H446 cells through activation of AMPK/FoxO3a signaling-Reference-Cited by-同舟云学术

Casticin suppresses the carcinogenesis of small cell lung cancer H446 cells through activation of AMPK/FoxO3a signaling

Published:2018-07-05 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Gong Qian¹,Cao Xiaozheng²,Cao Jianguo³,Yang Xiaohong⁴,Zeng Wenbin⁵

Affiliation:

1. Pharmacy Department, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, P.R.�China

2. School of Pharmaceutical Sciences, and Molecular Imaging Research Center, Central South University, Changsha, Hunan 410013, P.R.�China

3. Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha, Hunan 410013, P.R.�China

4. Department of Pharmaceutical Science, Medical College, Hunan Normal University, Changsha, Hunan 410013, P.R. China

5. School of Pharmaceutical Sciences, and Molecular Imaging Research Center, Central South University, Changsha, Hunan 410013, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects;Biomedicine & Pharmacotherapy;2024-07

2. Natural bioactive compounds and FOXO3a in cancer therapeutics: An update;Fitoterapia;2024-03

3. Natural sources, refined extraction, biosynthesis, metabolism, and bioactivities of dietary polymethoxyflavones (PMFs);Food Science and Human Wellness;2024-01

4. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology;Frontiers in Bioscience-Landmark;2023-12-26

5. Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches;Frontiers in Molecular Biosciences;2023-05-26